Innate Pharma IPHA
NASDAQ IPHA
$1.60 -0.10 (-5.88%)
At close: Sep 29, 2026 · 4:00 PM EDT

Innate Pharma (IPHA) Asset Utilization Ratio (2024 - 2025)

Updated

Innate Pharma's Asset Utilization Ratio was 0.68 in the quarter ended Dec 31, 2025, up 47.1% from 0.46 a year earlier.

Analysis

Innate Pharma (IPHA) Asset Utilization Ratio (2024 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Asset Utilization Ratio at Innate Pharma came in at 0.11, down 21.9% from the prior year.

  • In earlier years, Asset Utilization Ratio was 0.14 in the year ended Dec 31, 2024 (-57.2%), 0.32 in the year ended Dec 31, 2023 (+37.7%), 0.23 in the year ended Dec 31, 2022 (+169.1%) and 0.09 in the year ended Dec 31, 2021 (-59.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.49
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.47
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.52
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.44
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.53
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.40
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.58
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 0.47
10 Innate Pharma 159.32 Mn 159.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.68
Dec 31, 2024 0.46
API Access

Innate Pharma Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=IPHA&period=max&api_key=YOUR_API_KEY